I daresay, any deal with Luminex will be overwhelming in PR and underwhelming in revenue, similar to deals with Banglabs, Merck, Ebioscience and Affymetrix.
All evidence points to the fact that this technology is not disrupting at all.
getting a drug through to a phase 3 clinical trial would be quicker in it's progress
It may have a niche but nothing to justify the present market cap.
- Forums
- ASX - By Stock
- ADO
- Luminex Partner Trial Completion?
Luminex Partner Trial Completion?, page-5
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ADO (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $52.28M |
Open | High | Low | Value | Volume |
2.1¢ | 2.2¢ | 2.0¢ | $12.51K | 612.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 1790998 | 2.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.1¢ | 32423 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 1790998 | 0.020 |
9 | 1777381 | 0.019 |
4 | 468115 | 0.018 |
2 | 64748 | 0.017 |
1 | 420000 | 0.016 |
Price($) | Vol. | No. |
---|---|---|
0.021 | 32423 | 1 |
0.022 | 700616 | 2 |
0.023 | 322844 | 5 |
0.024 | 741966 | 3 |
0.025 | 1166439 | 12 |
Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
Featured News
ADO (ASX) Chart |